Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agents

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1399-1402

  Credito, Kim L ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4.3.0]NON 8 YL) 6 FLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINAFLOXACIN; CLINDAMYCIN; GARENOXACIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SITAFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTEROIDES FRAGILIS; CELL KILLING; COLONY FORMING UNIT; DRUG EFFECT; GROWTH INHIBITION; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; FLUOROQUINOLONES; HUMANS; INDOLES; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 0037379344     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1399-1402.2003     Document Type: Article

References (19)

1. Appelbaum, P. C. 1995. Quinolone activity against anaerobes: microbiological aspects. Drugs 49(Suppl. 2):76-80.
2. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1990. β-Lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob. Agents Chemother. 34:1546-1550.
3. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1991. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents. Antimicrob. Agents Chemother. 35:1214-1218.
4. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1993. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin and piperacillin/tazobactam. J. Antimicrob. Chemother. 32:223-231.
5. Bassetti, M., L. M. Dembry, P. A. Farrel, D. A. Callan, and V. T. Andriole. 2002. Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and β-lactams against gram-positive clinical isolates. Antimicrob. Agents Chemother. 46:234-238.
6. Ednie, L. M., M. R. Jacobs, and P. C. Appelbaum. 1998. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob. Agents Chemother. 42:2459-2462.
7. Fix, A. M., M. A. Pfaller, D. J. Biedenbach, M. L. Beach, and R. N. Jones. 2001. Comparative antimicrobial spectrum and activity of BMS284756 (T3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development. Int. J. Antimicrob. Agents 18:141-145.
8. Fung-Tomc, J. C., B. Minassian, B. Kolek, E. Huczko, L. Aleksunes, T. Stickle, T. Washo, E. Gradelski, L. Valera, and D. P. Bonner. 2000. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756. Antimicrob. Agents Chemother. 44:3351-3356.
9. Goldstein, E. J. C., D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. Fernandez. 2002. In vitro activities of the des-fluoro(6) quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections. Antimicrob. Agents Chemother. 46:866-870.
10. Gordon, K. A., M. A. Pfaller, R. N. Jones, and the SENTRY Participants Group. 2002. BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000). J. Antimicrob. Chemother. 49:851-855.
11. Gradelski, E., L. Valera, B. Kolek, D. Bonner, and J. Fung-Tome. 2001. Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS284756, fluoroquinolones, vancomycin and β-lactams. Int. J. Antimicrob. Agents 18:43-48.
12. Hoellman, D. B., L. M. Kelly, K. Credito, L. Anthony, L. M. Ednie, M. R. Jacobs, and P. C. Appelbaum. 2002. In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds. Antimicrob. Agents Chemother. 46:220-224.
13. Hoellman, D. B., L. M. Kelly, M. R. Jacobs, and P. C. Appelbaum. 2001. Comparative antianaerobic activity of BMS 284756. Antimicrob. Agents Chemother. 45:589-592.
14. Jacobs, M. R., S. K. Spangler, and P. C. Appelbaum. 1990. β-Lactamase production, β-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres. J. Antimicrob. Chemother. 26:361-370.
15. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed. Approved standard. NCCLS publication M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1997. Bactericidal activity of DU-6859a compared to activities of three quinolones, three β-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology. Antimicrob. Agents Chemother. 43:847-849.
17. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1997. Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes. J. Antimicrob. Chemother. 39(Suppl. B):23-27.
18. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
19. Takahata, M., J. Mitsuyama, Y. Yamashiro, M. Yonezawa, H. Araki, Y. Todo, S. Minami, Y. Watanabe, and H. Narita. 1999. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob. Agents Chemother. 43:1077-1084.